US Patent 11292792 Tricyclic CRBN ligands and uses thereof
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Arthur F. Kluge0
Matthew M. Weiss0
Nan Ji0
Yi Zhang0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
112927920
Date of Patent
April 5, 2022
0Patent Application Number
165025290
Date Filed
July 3, 2019
0Official Website
Patent Citations
Patent Primary Examiner
CPC Code
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Apr, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+167 characters)
US Patent 11292792 Tricyclic CRBN ligands and uses thereof
Article
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
Infobox
Is a
Patent applicant
Patent jurisdiction
Patent number
11292792
Date of patent
April 5, 2022
Patent application number
16502529
Date Filed
July 3, 2019
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11292792 Tricyclic CRBN ligands and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.